Profile
Kevin C.
Mannix is Vice President & Global Head-Capital Markets at Apotex Corp.
since 2024.
Formerly, Mr. Mannix was Head-Investor Relations at Teva North America, Senior Vice President-Investor Relations at BeOne Medicines Ltd., and Senior Vice President-Investor Relations at Teva Pharmaceutical Industries Ltd. from 2003 to 2021.
Mr. Mannix completed undergraduate education at Siena College in 1993.
Kevin Mannix active positions
| Companies | Position | Start |
|---|---|---|
Apotex Corp.
Apotex Corp. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products | Corporate Officer/Principal | 2024-09-30 |
Former positions of Kevin Mannix
| Companies | Position | End |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Investor Relations Contact | 2021-11-30 |
| BEIGENE LTD | Investor Relations Contact | - |
Teva North America | Investor Relations Contact | - |
Training of Kevin Mannix
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Siena College
Siena College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva North America | |
Apotex Corp.
Apotex Corp. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Kevin Mannix
















